(Q43225857)

16 November 2017

5 references

23 March 2019

22 June 2019

29 June 2019

23 November 2020

23 October 2022

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion (English)

1 reference

16 November 2017

adverse drug reaction

1 reference

23 November 2020

1 reference

1

1 reference

16 November 2017

2

1 reference

Giovanni Battista Migliori

16 November 2017

series ordinal

7

1 reference

16 November 2017

Rosella Centis

6

0 references

Enrico Girardi

series ordinal

4

object named as

Enrico Girardi

1 reference

16 November 2017

Haileyesus Getahun

3

1 reference

16 November 2017

Monica Sañé Schepisi

series ordinal

5

1 reference

16 November 2017

19 February 2015

1 reference

European Respiratory Journal

16 November 2017

1 April 2015

5 references

23 March 2019

22 June 2019

29 June 2019

23 November 2020

23 October 2022

6 references

16 November 2017

23 March 2019

22 June 2019

29 June 2019

23 November 2020

23 October 2022

45

1 reference

16 November 2017

4

1 reference

16 November 2017

1170-1173

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

16 November 2017

5 references

23 March 2019

22 June 2019

29 June 2019

23 November 2020

Adverse events with isoniazid preventive therapy: experience from a large trial

23 October 2022

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

Treatment of latent infection with Mycobacterium tuberculosis: update 2010.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

An official ATS statement: hepatotoxicity of antituberculosis therapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

The prognosis of a positive tuberculin reaction in childhood and adolescence

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

Isoniazid-associated hepatitis deaths: a review of available information

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4391659

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25700378

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1183/09031936.00216814

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

25700378

1 reference